{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T04:36:38Z","timestamp":1768019798080,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T00:00:00Z","timestamp":1756598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-05896-8","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T18:57:43Z","timestamp":1756666663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dermatological impacts of urological cancer treatments"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0194-0606","authenticated-orcid":false,"given":"Alejandra","family":"Sataray-Rodriguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damilola","family":"Oladinni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7323-9516","authenticated-orcid":false,"given":"Robert","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bailey","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Aust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Schur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-3041","authenticated-orcid":false,"given":"Scott","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-2724","authenticated-orcid":false,"given":"Jeffrey","family":"P. Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,31]]},"reference":[{"key":"5896_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"5896_CR2","doi-asserted-by":"publisher","unstructured":"Siegel RL, Miller KD, Jemal A, Cancer statistics (2019) CA Cancer J Clin 69(1):7\u201334. https:\/\/doi.org\/10.3322\/caac.21551","DOI":"10.3322\/caac.21551"},{"key":"5896_CR3","unstructured":"Leslie SW, Soon-Sutton TL, Aeddula NR (2025) Bladder Cancer. [Updated 2024 Aug 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK536923\/"},{"key":"5896_CR4","unstructured":"Pandey J, Syed W (2025) Renal Cancer. [Updated 2024 Oct 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558975\/"},{"key":"5896_CR5","unstructured":"Gaddam SJ, Bicer F, Chesnut GT (2025) Testicular Cancer [Updated 2023 May 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK563159\/"},{"key":"5896_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1161\/CIRCRESAHA.113.300218","volume":"113","author":"B Ky","year":"2013","unstructured":"Ky B, Vejpongsa P, Yeh ETH, Force T, Moslehi JJ (2013) Emerging paradigms in cardiomyopathies associated with cancer therapies. Circ Res 113:754\u2013764","journal-title":"Circ Res"},{"key":"5896_CR7","first-page":"115","volume":"8","author":"KG Metri","year":"2013","unstructured":"Metri KG, Bhargav H, Chowdhury P, Koka PS (2013) Ayurveda for chemo-radiotherapy induced side effects in cancer patients. J Stem Cells 8:115\u2013129","journal-title":"J Stem Cells"},{"key":"5896_CR8","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/nrc1970","volume":"6","author":"ME Lacouture","year":"2006","unstructured":"Lacouture ME (2006) Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 6:803\u2013812","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"5896_CR9","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.3390\/cancers16142526","volume":"16","author":"R Ladwa","year":"2024","unstructured":"Ladwa R, Fogarty G, Chen P, Grewal G, McCormack C, Mar V, Kerob D, Khosrotehrani K (2024) Management of skin toxicities in cancer treatment: an australian\/new Zealand perspective. Cancers (Basel) 16(14):2526. https:\/\/doi.org\/10.3390\/cancers16142526PMID: 39061166; PMCID: PMC11274446","journal-title":"Cancers (Basel)"},{"issue":"2","key":"5896_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cancers17020251","volume":"17","author":"D Chowdhury","year":"2025","unstructured":"Chowdhury D, Chin L, Odabashian R, Fawaz A, Canil C, Ong M, Kirchhof MG, Reaume MN, Beltran-Bless AA, Savard MF, Tsoulis DJ, Boss\u00e9 D (2025) Diagnosis and management of skin toxicities in systemic treatment of genitourinary cancers. Cancers 17(2):251. https:\/\/doi.org\/10.3390\/cancers17020251","journal-title":"Cancers"},{"issue":"3","key":"5896_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jaad.2020.08.005","volume":"85","author":"AM Rossi","year":"2021","unstructured":"Rossi AM, Hibler BP, Navarrete-Dechent C, Lacouture ME (2021) Restorative oncodermatology: diagnosis and management of dermatologic sequelae from cancer therapies. J Am Acad Dermatol 85(3):693\u2013707. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.005","journal-title":"J Am Acad Dermatol"},{"key":"5896_CR12","doi-asserted-by":"publisher","first-page":"1071983","DOI":"10.3389\/fimmu.2023.1071983","volume":"14","author":"T Watanabe","year":"2023","unstructured":"Watanabe T, Yamaguchi Y (2023) Cutaneous manifestations associated with immune checkpoint inhibitors. Front Immunol 14:1071983. https:\/\/doi.org\/10.3389\/fimmu.2023.1071983","journal-title":"Front Immunol"},{"issue":"7","key":"5896_CR13","doi-asserted-by":"publisher","first-page":"e0253143","DOI":"10.1371\/journal.pone.0253143","volume":"16","author":"Y Li","year":"2021","unstructured":"Li Y, Kong Q, Wei H, Wang Y (2021) Comparison of the complications between minimally invasive surgery and open surgical treatments for early-stage cervical cancer: A systematic review and meta-analysis. PLoS ONE 16(7):e0253143. https:\/\/doi.org\/10.1371\/journal.pone.0253143","journal-title":"PLoS ONE"},{"issue":"2","key":"5896_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.36849\/JDD.8401","volume":"24","author":"AN Sharma","year":"2025","unstructured":"Sharma AN, Birda A, Park M, Choe S, Salas J, Kincaid C, Mesinkovska NA (2025) Insights into demographics, comorbidities, and risk factors in keloids and hypertrophic scars: A retrospective study. J Drugs Dermatology: JDD 24(2):212\u2013215. https:\/\/doi.org\/10.36849\/JDD.8401","journal-title":"J Drugs Dermatology: JDD"},{"issue":"3","key":"5896_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/wrr.12694","volume":"27","author":"AR Alfonso","year":"2019","unstructured":"Alfonso AR, Kantar RS, Ramly EP, Daar DA, Rifkin WJ, Levine JP, Ceradini DJ (2019) Diabetes is associated with an increased risk of wound complications and readmission in patients with surgically managed pressure ulcers. Wound Repair Regeneration: Official Publication Wound Healing Soc [and] Eur Tissue Repair Soc 27(3):249\u2013256. https:\/\/doi.org\/10.1111\/wrr.12694","journal-title":"Wound Repair Regeneration: Official Publication Wound Healing Soc [and] Eur Tissue Repair Soc"},{"issue":"4","key":"5896_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.suc.2020.05.002","volume":"100","author":"RT Beyene","year":"2020","unstructured":"Beyene RT, Derryberry SL Jr, Barbul A (2020) The effect of comorbidities on wound healing. Surg Clin North Am 100(4):695\u2013705. https:\/\/doi.org\/10.1016\/j.suc.2020.05.002","journal-title":"Surg Clin North Am"},{"key":"5896_CR17","doi-asserted-by":"publisher","unstructured":"Schneider BJ, Naidoo J, Santomasso BD, Lacchetti C, Adkins S, Anadkat M, Atkins MB, Brassil KJ, Caterino JM, Chau I, Davies, MJ, Ernstoff MS, Fecher L, Ghosh M, Jaiyesimi I, Mammen JS, Naing A, Nastoupil LJ, Phillips T, Porter LD, Bollin K (2021) Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. J Clin Oncol 39(36):4073\u20134126. https:\/\/doi.org\/10.1200\/JCO.21.01440","DOI":"10.1200\/JCO.21.01440"},{"key":"5896_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2147\/IJN.S280187","volume":"16","author":"X Hu","year":"2021","unstructured":"Hu X, Dong M, Liang X, Liu Z, Li Q (2021) Reactive oxygen Species-Mediated inflammation and apoptosis in Hand-Foot syndrome induced by pegylated liposomal doxorubicin. Int J Nanomed 16:471\u2013480. https:\/\/doi.org\/10.2147\/IJN.S280187","journal-title":"Int J Nanomed"},{"issue":"4","key":"5896_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s40257-020-00519-x","volume":"21","author":"KA Ashack","year":"2020","unstructured":"Ashack KA, Kuritza V, Visconti MJ, Ashack L (2020) Dermatologic sequelae associated with radiation therapy. Am J Clin Dermatol 21(4):541\u2013555. https:\/\/doi.org\/10.1007\/s40257-020-00519-x","journal-title":"Am J Clin Dermatol"},{"issue":"3 Pt 2","key":"5896_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/jid.2011.411","volume":"132","author":"JL Ryan","year":"2012","unstructured":"Ryan JL (2012) Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol 132(3 Pt 2):985\u2013993. https:\/\/doi.org\/10.1038\/jid.2011.411","journal-title":"J Invest Dermatol"},{"issue":"3","key":"5896_CR21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40257-024-00847-2","volume":"25","author":"A Belzer","year":"2024","unstructured":"Belzer A, Pach JJ, Valido K, Leventhal JS (2024) The impact of dermatologic adverse events on the quality of life of oncology patients: A review of the literature. Am J Clin Dermatol 25(3):435\u2013445. https:\/\/doi.org\/10.1007\/s40257-024-00847-2","journal-title":"Am J Clin Dermatol"},{"key":"5896_CR22","doi-asserted-by":"publisher","first-page":"104420","DOI":"10.1016\/j.critrevonc.2024.104420","volume":"200","author":"R Daher","year":"2024","unstructured":"Daher R, Ruplin A, Gupta S, Spiess PE, Kamat AM, Cigliola A, Tateo V, Mercinelli C, Grivas P, Necchi A (2024) The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies. Crit Rev Oncol\/Hematol 200:104420. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104420","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"9","key":"5896_CR23","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/jdv.12082","volume":"27","author":"B Dreno","year":"2013","unstructured":"Dreno B, Bensadoun RJ, Humbert P, Krutmann J, Luger T, Triller R, Rougier A, Seit\u00e9 S (2013) Algorithm for dermocosmetic use in the management of cutaneous side-effects associated with targeted therapy in oncology. J Eur Acad Dermatol Venereol 27(9):1071\u20131080. https:\/\/doi.org\/10.1111\/jdv.12082","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5896_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/207084","volume":"2010","author":"N Makrilia","year":"2010","unstructured":"Makrilia N, Syrigou E, Kaklamanos I, Manolopoulos L, Saif MW (2010) Hypersensitivity reactions associated with platinum antineoplastic agents: A systematic review. Met-Based Drugs 2010:1\u201311. https:\/\/doi.org\/10.1155\/2010\/207084","journal-title":"Met-Based Drugs"},{"key":"5896_CR25","doi-asserted-by":"publisher","unstructured":"Deutsch A, Leboeuf NR, Lacouture ME, McLellan BN (2020) Dermatologic adverse events of systemic anticancer therapies: cytotoxic chemotherapy, targeted therapy, and immunotherapy. Am Soc Clin Oncol Educational Book 40485\u2013500. https:\/\/doi.org\/10.1200\/EDBK_289911","DOI":"10.1200\/EDBK_289911"},{"issue":"3","key":"5896_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.14710\/dmj.v12i3.37095","volume":"12","author":"F Jesslyn","year":"2023","unstructured":"Jesslyn F (2023) An overview of chemotherapy side effects on patients with prostate cancer, bladder cancer, and testicular cancer at Haji Adam Malik general hospital Medan from 2020\u20132022. Jurnal Kedokteran Diponegoro (diponegoro Med Journal) 12(3):98\u2013103. https:\/\/doi.org\/10.14710\/dmj.v12i3.37095","journal-title":"Jurnal Kedokteran Diponegoro (diponegoro Med Journal)"},{"key":"5896_CR27","doi-asserted-by":"publisher","unstructured":"\u0160eparovi\u0107 R, Pavlovi\u0107 M, Silovski T, Te\u010di\u0107 Vuger A (2018) Rapid hair depigmentation in patient treated with pazopanib. https:\/\/doi.org\/10.1136\/bcr-2018-224209. BMJ Case Reports, bcr-2018-224209","DOI":"10.1136\/bcr-2018-224209"},{"issue":"4","key":"5896_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/clon.2000.9157","volume":"12","author":"JM O\u2019Sullivan","year":"2000","unstructured":"O\u2019Sullivan JM, Gribbin A, Taylor J, O\u2019Neill L, Cosgrove S, Armstrong JG (2000) Complications of treatment with local field external beam radiotherapy for localized prostate cancer. Clin Oncol (R Coll Radiol (G B)) 12(4):217\u2013221. https:\/\/doi.org\/10.1053\/clon.2000.9157","journal-title":"Clin Oncol (R Coll Radiol (G B))"},{"key":"5896_CR29","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.humpath.2023.04.014","volume":"140","author":"D Haynes","year":"2023","unstructured":"Haynes D, Morgan EE, Chu EY (2023) Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings. Hum Pathol 140:129\u2013143. https:\/\/doi.org\/10.1016\/j.humpath.2023.04.014","journal-title":"Hum Pathol"},{"issue":"11","key":"5896_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/nejmoa1613683","volume":"376","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, De Wit R, Vaughn DJ, Fradet Y, Lee J-L, Fong L, Vogelzang NJ, Climent MA, Petrylak DP, Choueiri TK, Necchi A, Gerritsen W, Gurney H, Quinn DI, Culine S, Sternberg CN, Mai Y, Poehlein CH, Perini RF, Bajorin DF (2017) Pembrolizumab as Second-Line therapy for advanced urothelial carcinoma. N Engl J Med 376(11):1015\u20131026. https:\/\/doi.org\/10.1056\/nejmoa1613683","journal-title":"N Engl J Med"},{"issue":"11","key":"5896_CR31","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.annonc.2023.08.016","volume":"34","author":"JE Rosenberg","year":"2023","unstructured":"Rosenberg JE, Powles T, Sonpavde GP, Loriot Y, Duran I, Lee J-L, Matsubara N, Vulsteke C, Castellano D, Mamtani R, Wu C, Matsangou M, Campbell M, Petrylak DP (2023) EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab Vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma. Ann Oncol 34(11):1047\u20131054. https:\/\/doi.org\/10.1016\/j.annonc.2023.08.016","journal-title":"Ann Oncol"},{"key":"5896_CR32","doi-asserted-by":"publisher","unstructured":"Wang D, Sun K, Wang T, Zhang D, Sun F, Cui Y, Zhao H, Wu J (2021) Adverse effects and toxicity of immune checkpoint inhibitors for patients with urothelial carcinoma. Front Pharmacol 12. https:\/\/doi.org\/10.3389\/fphar.2021.710943","DOI":"10.3389\/fphar.2021.710943"},{"issue":"9","key":"5896_CR33","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1001\/jamadermatol.2018.1912","volume":"154","author":"LL Wang","year":"2018","unstructured":"Wang LL, Patel G, Chiesa-Fuxench ZC, McGettigan S, Schuchter L, Mitchell TC, Ming ME, Chu EY (2018) Timing of onset of adverse cutaneous reactions associated with programmed cell death protein 1 inhibitor therapy. JAMA Dermatology 154(9):1057\u20131061. https:\/\/doi.org\/10.1001\/jamadermatol.2018.1912","journal-title":"JAMA Dermatology"},{"issue":"6","key":"5896_CR34","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.adengl.2019.05.003","volume":"110","author":"O Sanmart\u00edn","year":"2019","unstructured":"Sanmart\u00edn O, Beato C, Suh-Oh HJ, Arag\u00f3n I, Espa\u00f1a A, Majem M, Segura S, G\u00farpide A, Botella R, Gr\u00e1valos C (2019) Clinical management of cutaneous adverse events in patients on chemotherapy: A National consensus statement by the Spanish academy of dermatology and venereology and the Spanish society of medical oncology. Actas Dermo-Sifiliogr\u00e1ficas (English Edition) 110(6):448\u2013459. https:\/\/doi.org\/10.1016\/j.adengl.2019.05.003","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"issue":"5","key":"5896_CR35","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.clgc.2014.04.001","volume":"12","author":"JN Ruiz","year":"2014","unstructured":"Ruiz JN, Belum VR, Creel P, Cohn A, Ewer M, Lacouture ME (2014) Current practices in the management of adverse events associated with targeted therapies for advanced renal cell carcinoma: a National survey of oncologists. Clin Genitourin Cancer 12(5):341\u2013347. https:\/\/doi.org\/10.1016\/j.clgc.2014.04.001","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"5896_CR36","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/10547738211030389","volume":"31","author":"G Villa","year":"2022","unstructured":"Villa G, Galli E, Azzimonti V, Doneda M, Giannetta N, Manara DF (2022) Empowerment-Based education in urological patients: A scoping review. Clin Nurs Res 31(4):666\u2013689. https:\/\/doi.org\/10.1177\/10547738211030389","journal-title":"Clin Nurs Res"},{"issue":"3","key":"5896_CR37","doi-asserted-by":"publisher","first-page":"37518","DOI":"10.52965\/001c.37518","volume":"10","author":"D Anderson","year":"2022","unstructured":"Anderson D, Razzak AN, McDonald M et al (2022) Mental health in urologic oncology. Health Psychol Res 10(3):37518 Published 2022 Aug 20. https:\/\/doi.org\/10.52965\/001c.37518","journal-title":"Health Psychol Res"},{"key":"5896_CR38","doi-asserted-by":"publisher","first-page":"e12915","DOI":"10.1590\/1414-431X2023e12915","volume":"56","author":"C Xia","year":"2023","unstructured":"Xia C, Zhao X, Li B, Qi B, Hong Y (2023) Loneliness, spiritual well-being, and death perception, as well as their risk factors in urological cancer patients. Brazilian J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologicas 56:e12915. https:\/\/doi.org\/10.1590\/1414-431X2023e12915","journal-title":"Brazilian J Med Biol Res = Revista Brasileira De Pesquisas Medicas E Biologicas"},{"issue":"1","key":"5896_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11764-021-01007-9","volume":"16","author":"J Bowie","year":"2022","unstructured":"Bowie J, Brunckhorst O, Stewart R, Dasgupta P, Ahmed K (2022) Body image, self-esteem, and sense of masculinity in patients with prostate cancer: a qualitative meta-synthesis. J Cancer Survivorship: Res Pract 16(1):95\u2013110. https:\/\/doi.org\/10.1007\/s11764-021-01007-9","journal-title":"J Cancer Survivorship: Res Pract"},{"issue":"2","key":"5896_CR40","doi-asserted-by":"publisher","first-page":"178","DOI":"10.22465\/juo.244600060003","volume":"22","author":"M DeSanto","year":"2024","unstructured":"DeSanto M, Annie FH, Deslich S, Cato T, Davis C, Hale N (2024) Effects of neoadjuvant chemotherapy on rates of depression in muscle invasive bladder cancer. J Urologic Oncol 22(2):178\u2013182. https:\/\/doi.org\/10.22465\/juo.244600060003","journal-title":"J Urologic Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05896-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-05896-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-05896-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T22:03:30Z","timestamp":1767996210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-05896-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5896"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-05896-8","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,31]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"521"}}